Oncology Central

Role of cyclin polymorphisms in predicting outcome of 5-fluorouracil-based chemotherapy in colorectal cancer: one piece in a complex puzzle


The last 20 years has witnessed a significant increase in our knowledge and understanding of the complex pathways and molecular signals that are deregulated in colorectal cancer (CRC). This remarkable progress has been made possible through numerous technological advances and extensive collaborative efforts within the pharmaceutical, clinical and research communities and has led to the identification of promising new drug targets and the development of new drugs.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.